Cancer screening plays a crucial role in the early detection and prevention of cancer, significantly increasing the likelihood of successful treatment and improved survival rates. Routine screening methods, such as mammograms for breast cancer, colonoscopies for colorectal cancer, and Pap tests for cervical cancer, are widely employed to catch cancer early. Innovations in cancer research have led to the development of cutting-edge screening techniques, such as liquid biopsies and enhanced imaging technologies, which offer more precise and less invasive detection options. Current research efforts are focused on refining these methods to enhance their accuracy and reduce false positives and negatives. Additionally, the use of genetic and molecular markers is gaining traction, allowing for tailored screening approaches based on individual risk profiles. These advancements highlight the essential role of cancer screening in lowering mortality rates and enhancing patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States